Careium (CARE) Q3 2025 earnings summary

Executive summary

• Q3 2025 net sales increased by 6.0% to SEK 213.7m, with currency-adjusted growth of 9.4%.

• Gross margin improved to 44.2%, and free cash flow rose to SEK 14.1m.

• Product sales surged 77.5%, while service sales declined 10.3%.

• Operating profit (EBIT) was SEK 14.3m, impacted by SEK 4.6m in one-off administrative costs.

• CEO transition occurred in August 2025, with new initiatives underway.

Financial highlights

• Net sales: SEK 213.7m in Q3 (up 6.0% year-over-year); nine-month net sales: SEK 623.2m (down 2.9%).

• Gross margin: 44.2% in Q3 (up from 42.8%); nine-month gross margin: 44.0%.

• EBITDA: SEK 31.8m in Q3 (margin 14.9%, down from 17.0%).

• EBIT: SEK 14.3m in Q3 (margin 6.7%, down from 8.2%).

• Profit for Q3: SEK 8.6m (down 21.0% year-over-year); earnings per share SEK 0.32 (down 23.1%).

Outlook and guidance

• Net sales, profitability, and free cash flow before acquisitions are expected to increase in 2025 compared to 2024.

• Impact of financial lease accounting will be significantly reduced from Q1 2026, improving reporting clarity.